Search

You searched for "prostatic"

568 results found
Urology journal cover image.

Importance of PSA variation – an analysis of PLCO trial data

1 January 2016 | | URO - Urologic Oncology
This study looks specifically at the group of patients in the intervention arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial (PLCO), to investigate variations in prostate specific antigen (PSA) level. They have specifically included only patients who...

The Future of Prostate Cancer Imaging: What’s Next?

7 January 2026
The pioneering charity Prostate Cancer Research convened industry leaders, NHS experts and patients for a webinar exploring how artificial intelligence (AI) is transforming prostate cancer imaging and clinical pathways. The session provided valuable insights for healthcare professionals seeking innovative approaches...

The scent of Ethiopia: a personal story – part 1

1 April 2016 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Functional / Reconstructive Urology, URO - Neurourology, URO - Paediatrics, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Background The year was 2004; I had just moved to the UK as a young house officer and finished my observership programme at Great Ormond Street Hospital in London. I was inspired by greats like Patrick Duffy and Phillip Ransley,...

Rotterdam Prostate Cancer Risk app

1 July 2014 | | URO - Urologic Oncology, URO - Technology
The widespread use of prostate specific antigen (PSA) testing has led to diagnostic difficulties for patients and urologists. The sensitivity and specificity characteristics of PSA are far from optimal. To try and improve the predictive accuracy of PSA measurements, nomograms...

First-of-its-kind international study launches to revolutionise quality of life for Black men with prostate cancer

24 August 2026
BALANCE will generate pioneering evidence to fill gaps in our understanding of the challenges Black men face with prostate cancer and the support they need, making changes possible which will improve Black men's quality of life while navigating the disease....

Join Prostate Cancer Research Free Webinar for Healthcare Professionals

11 December 2025
Managing Sexual Side Effects After Prostate Cancer: A Patient & Therapist Perspective Date: 20 January 2026 — 6.00pm (London)Register: https://zoom.us/webinar/register/WN_CstOkvaUSNSg_xlFI1Z27w Why attend?Sexual side effects remain one of the most challenging and under-discussed consequences of prostate cancer treatment. This focused webinar...

Prostate Progress – Information for Healthcare Professionals

9 September 2026 | Urology News
We at Prostate Cancer Research wanted to let you know about an important development regarding Prostate Progress, our patient information register. From now and over the coming months, all individuals identified through NHS records as having a diagnosis of prostate...

COVID-19 cuts prostate cancer referrals in half

7 October 2020 | URO - Urologic Oncology
Charity warns that 3500 men risk being diagnosed with incurable cancer as referrals drop to lowest in 10 years Urgent referrals for urological cancers have dropped by half in England (49.5%) compared to the same period last year as the...

New study shows UK may finally be ready for prostate cancer screening

27 February 2023 | URO - Urologic Oncology
Prostate Cancer UK study shows tens of thousands fewer men each year face unnecessary harm thanks to new screening techniques. New research by Prostate Cancer UK shows that the UK may finally be in a position to roll out a...

Focal therapies in prostate cancer

1 November 2018 | | URO - Urologic Oncology, URO - Technology
The standard of care in the management of prostate cancer has, to date, always been to treat the whole gland. This has ranged from surveillance, surgical excision / prostatectomy or external beam radiotherapy / whole gland brachytherapy. With the evolution...

MOWOOT II Intestinal Transit Management System

1 November 2020 | Research & Development
MOWOOT II is an intermittent colonic exo-peristaltic therapy system for intestinal transit disorders, such as slow transit constipation. MOWOOT II utilises advanced pneumatic technology to treat and prevent chronic constipation without laxatives, enemas...

Does empowering men on active surveillance for prostate cancer improve patient compliance and reduce conversion to treatment?

4 November 2025 | | URO - Core Urology, URO - Urologic Oncology
Active surveillance is a major treatment option for patients with favourable prognosis prostate cancer, such as those regarded as Cambridge Prognostic Group (CPG) 1 and 2 [1]. The rationale for this management strategy is the lack of survival benefit from...